Recorded on 29 April 2020, as part of The Royal Society of Medicine’s events programme. Organised by the Rheumatology & Rehabilitation Section. Recently a number of drugs, which have been used in rheumatology for decades, have been found to be beneficial in the various stages of COVID-19, according to case reports and limited studies. This webinar looks at the evidence behind these reports and studies, and the new trials which will involve the use of these drugs. Interviewed by, Dr Stephanie Kaye-Barrett MD, FRCP, Consultant Physician and Rheumatologist, and Medical Director at the Chelsea Rheumatology Clinic